VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Med-Fine Family: Ansong Tech Closes ~CNY 150M C3 Round; Lingke Pharma's NDA for Zeprucitinib Accepted by NMPA
Med-Fine Family: Ansong Tech Closes ~CNY 150M C3 Round; Lingke Pharma's NDA for Zeprucitinib Accepted by NMPA
May 29, 2026 09:00 CST Updated 12:01
Share:
Allink Biotherapeutics
Innovative Drug Developer
Lynk Pharmaceuticals
FIC/BIC Small Molecule Drug Developer